Evrofarma SA (EVROF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Evrofarma SA (EVROF) has a cash flow conversion efficiency ratio of 0.108x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.52 Million ≈ $1.77 Million USD) by net assets (€14.03 Million ≈ $16.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Evrofarma SA worth for the company's overall valuation and market capitalisation.
Evrofarma SA - Cash Flow Conversion Efficiency Trend (2014–2022)
This chart illustrates how Evrofarma SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Evrofarma SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Evrofarma SA ranked by their cash flow conversion efficiency. Explore earnings quality score of Evrofarma SA to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CSL Finance Limited
NSE:CSLFINANCE
|
-0.081x |
|
Toung LoongTextile Mfg Co Ltd
TWO:4401
|
0.064x |
|
Hedef Girisim Sermayesi
IS:HDFGS
|
-0.162x |
|
Daehan New Pharm Co. Ltd
KQ:054670
|
0.034x |
|
Sigong Tech Co. Ltd
KQ:020710
|
-0.056x |
|
5E Advanced Materials Inc
NASDAQ:FEAM
|
-0.101x |
|
Drb Industrial
KO:163560
|
0.027x |
|
Svolder AB (publ)
ST:SVOL-A
|
0.012x |
Annual Cash Flow Conversion Efficiency for Evrofarma SA (2014–2022)
The table below shows the annual cash flow conversion efficiency of Evrofarma SA from 2014 to 2022. View today's stock price for Evrofarma SA for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €14.03 Million ≈ $16.40 Million |
€2.44 Million ≈ $2.85 Million |
0.174x | +372.38% |
| 2021-12-31 | €12.61 Million ≈ $14.74 Million |
€-805.00K ≈ $-941.13K |
-0.064x | -156.73% |
| 2020-12-31 | €12.95 Million ≈ $15.14 Million |
€1.46 Million ≈ $1.70 Million |
0.113x | -24.84% |
| 2019-12-31 | €11.87 Million ≈ $13.88 Million |
€1.78 Million ≈ $2.08 Million |
0.150x | -23.84% |
| 2018-12-31 | €11.65 Million ≈ $13.63 Million |
€2.29 Million ≈ $2.68 Million |
0.197x | -32.08% |
| 2017-12-31 | €10.73 Million ≈ $12.54 Million |
€3.11 Million ≈ $3.63 Million |
0.290x | +173.21% |
| 2016-12-31 | €10.20 Million ≈ $11.93 Million |
€1.08 Million ≈ $1.26 Million |
0.106x | -25.34% |
| 2015-12-31 | €9.79 Million ≈ $11.45 Million |
€1.39 Million ≈ $1.63 Million |
0.142x | +51.87% |
| 2014-12-31 | €9.27 Million ≈ $10.83 Million |
€866.00K ≈ $1.01 Million |
0.093x | -- |
About Evrofarma SA
Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, and cheese products, as well as fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.